首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1606508

日本血管外科和血管內手術市場 - 2024-2031

Japan Vascular Surgery and Endovascular Procedures Market - 2024-2031

出版日期: 2024年12月04日 | 出版商:

DataM Intelligence | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

日本血管手術和血管內手術市場於 2023 年達到 1.225 億美元，預計到 2031 年將達到 2.24 億美元，在 2024-2031 年預測期間複合年成長率為 7.9%。

血管外科是一門醫學專業，專注於診斷和治療影響血管系統（包括動脈、靜脈和淋巴管）的疾病和病症。這些結構對於全身血液和淋巴循環至關重要。血管外科醫師進行傳統的開放式手術和微創手術，以恢復血流或消除血管阻塞。血管內手術是微創技術，用於透過小穿刺或切口治療血管疾病。這些手術涉及使用導管、電線和其他透過血管引導的裝置來進行治療，而不需要進行開放性手術。

在人口老化、血管疾病盛行率上升以及微創技術進步等因素的推動下，日本血管手術和血管內手術的市場需求一直穩定成長。例如，根據日本血管外科學會的數據，在動脈瘤治療領域，登記了包括髂總動脈瘤在內的腹主動脈瘤（AAA）20,160例，其中61.6%接受了血管內動脈瘤修復術（EVAR）治療。在 AAA 病例中，1,794 例（8.9%）登記為破裂 AAA。

市場動態：

驅動程式和限制

人口老化加劇

老齡化人口的增加正在顯著推動日本血管手術和血管內手術市場的發展，預計將在預測期內推動該市場的發展。隨著老年人口比例持續上升，血管疾病的盛行率也隨之增加，而血管疾病在老年人中更為常見。這種人口結構的變化極大地影響了對傳統血管手術和微創血管內治療的需求。

隨著人們年齡的成長，他們更容易患周邊動脈疾病（PAD）、主動脈瘤、靜脈曲張和中風等疾病，所有這些疾病通常都需要血管干預。例如，根據世界經濟論壇的數據，日本的人口老化程度越來越嚴重。目前，該國超過十分之一的人年齡在 80 歲或以上。近三分之一的人口年齡超過 65 歲——估計為 3,623 萬人。中風風險隨著年齡的成長而增加，特別是由於頸動脈疾病，這是老年人常見的血管疾病

血管手術和血管內手術相關的高成本

與血管手術和血管內手術相關的高成本預計將阻礙預測期內市場的成長。血管內裝置（例如支架、移植物和線圈）的製造和使用成本昂貴。

血管內動脈瘤修復 (EVAR) 需要專門的移植物和影像設備，其成本可能明顯高於傳統手術。例如，根據牛津學院的數據，EVAR 的平均醫療費用為每位患者 35,2000 日圓。

此外，根據國立衛生研究院進行的一項研究，開放性手術修復 (OR) 與 EVAR 的平均成本如下：診斷程序組合 (DPC) 分別為 632,370 日元和 490,050 日元，這一數字非常顯著；麻醉費分別為 123,540 日圓和 86,220 日圓，材料分別為 257,770 日圓和 2,113,280 日圓。因此，開放式維修和 EVAR 的平均總成本分別為 1,825,830 日圓和 3,159,270 日圓。

Vascular surgery is a medical specialty focused on diagnosing and treating diseases and conditions affecting the vascular system, which includes arteries, veins, and lymphatic vessels. These structures are essential for circulating blood and lymph throughout the body. Vascular surgeons perform both traditional open surgeries and minimally invasive procedures to restore blood flow or remove blockages in the vessels. Endovascular procedures are minimally invasive techniques used to treat vascular conditions through small punctures or incisions. These procedures involve the use of catheters, wires, and other devices guided through blood vessels to perform treatments without the need for open surgery.

The market demand for vascular surgery and endovascular procedures in Japan has been growing steadily, driven by factors such as the aging population, rising prevalence of vascular diseases, and advancements in minimally invasive technologies. For instance, according to the Japanese Society for Vascular Surgery, in the field of aneurysm treatment, 20,160 cases of abdominal aortic aneurysm (AAA) including common iliac aneurysms were registered, and 61.6% were treated by endovascular aneurysm repair (EVAR). Among AAA cases, 1,794 (8.9%) cases were registered as ruptured AAA.

Market Dynamics: Drivers & Restraints

Rising aging population

The rising aging population is significantly driving the Japan vascular surgery and endovascular procedures market and is expected to drive the market over the forecast period. As the proportion of elderly people continues to rise, there is an increased prevalence of vascular diseases, which are more common among older individuals. This demographic shift is significantly impacting the demand for both traditional vascular surgery and minimally invasive endovascular treatments.

As people age, they are more susceptible to conditions like peripheral arterial disease (PAD), aortic aneurysms, varicose veins, and stroke all of which often require vascular interventions. For instance, according to the World Economic Forum, Japan is getting ever greyer. More than 1 in 10 people in the country are now aged 80 or older. Almost a third of its population is over 65 - an estimated 36.23 million. Stroke risk rises with age, particularly due to carotid artery disease, which is a common vascular condition in older people

High cost associated with vascular surgery and endovascular procedures

The high cost associated with vascular surgery and endovascular procedures is expected to hamper the growth of the market over the forecast period. Endovascular Devices such as stents, grafts, and coils are expensive to manufacture and use.

The cost of Endovascular Aneurysm Repair (EVAR), which requires specialized grafts and imaging equipment, can be significantly higher than traditional surgery. For instance, according to the Oxford Academy, the average medical cost for EVAR was 35,2000 Japanese Yen per patient.

Additionally, according to a study conducted by the National Institute of Health, the mean costs for open surgical repair (OR) versus EVAR were as follows, Diagnosis Procedure Combination (DPC) ¥632,370 versus ¥490,050, respectively, which was significant; anesthesia, ¥123,540 versus ¥86,220, respectively and materials, ¥257,770 versus ¥2,113,280, respectively. Thus, the mean total cost was ¥1,825,830 versus ¥3,159,270 for open repair and EVAR, respectively.

Segment Analysis

The Japan vascular surgery and endovascular procedures market is segmented based on procedure, product type and end-user.

Procedure:

The endovascular repair segment is expected to dominate the Japan vascular surgery and endovascular procedures market share

The endovascular repair segment holds a major portion of the Japan vascular surgery and endovascular procedures market share and is expected to continue to hold a significant portion of the market share over the forecast period. Endovascular repair involves the use of minimally invasive techniques to treat vascular conditions such as abdominal aortic aneurysms (AAA) and peripheral arterial disease (PAD). These procedures use small incisions or punctures, making them far less invasive than traditional open surgery.

The demand for EVAR has surged in Japan as patients prefer less invasive procedures that offer faster recovery times and shorter hospital stays. For instance, according to the J-Stage, as of 2020, EVAR accounted for over 60% of AAA cases in Japan, indicating its dominance in the treatment of aneurysms.

Endovascular repair has benefited from technological innovations in medical devices, imaging, and procedural techniques. The introduction of advanced stents, drug-eluting balloons and robotic-assisted navigation has made endovascular repair even more efficient, safe, and accessible. This has contributed to the widespread adoption of these procedures across Japan.

Competitive Landscape

The major Japan players in the vascular surgery and endovascular procedures market include Terumo Corporation, Olympus Corporation, FUJIFILM Holdings Corporation, Mizuho Medical Co., Ltd., Nipro Corporation, Shimadzu Corporation, SB-KAWASUMI LABORATORIES, INC., ASAHI INTECC CO., LTD., Medtronic plc, Boston Scientific Corporation and among others.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan vascular surgery and endovascular procedures market report would provide approximately 39 tables, 31 figures and 197 pages.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Procedure
3.2. Snippet by Product Type
3.3. Snippet by End-User

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising Aging Population
  - 4.1.1.2. Advancements in Minimally Invasive Techniques
- 4.1.2. Restraints
  - 4.1.2.1. High Cost Associated with Vascular Surgery and Endovascular Procedures
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs

6. By Procedure

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
- 6.1.2. Market Attractiveness Index, By Procedure
6.2. Aneurysm Repair*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Bypass Surgery
6.4. Carotid Angioplasty and Stenting
6.5. Endovascular Repair
6.6. Others

7. By Product Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 7.1.2. Market Attractiveness Index, By Product Type
7.2. Stents and Stent Grafts*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Endovascular Tools
7.4. Scissors and Forceps
7.5. Needle Holders
7.6. Others

8. By End-User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Hospitals
8.4. Surgical Centers
8.5. Academic and Research Institutions
8.6. Others

9. Competitive Landscape

9.1. Competitive Scenario
9.2. Market Positioning/Share Analysis
9.3. Mergers and Acquisitions Analysis

10. Company Profiles

10.1. Terumo Corporation*
- 10.1.1. Company Overview
- 10.1.2. Product Portfolio and Description
- 10.1.3. Financial Overview
- 10.1.4. Key Developments
10.2. Olympus Corporation
10.3. FUJIFILM Holdings Corporation
10.4. Mizuho Medical Co., Ltd.
10.5. Nipro Corporation
10.6. Shimadzu Corporation
10.7. SB-KAWASUMI LABORATORIES, INC.
10.8. ASAHI INTECC CO., LTD.
10.9. Medtronic plc
10.10. Boston Scientific Corporation

LIST NOT EXHAUSTIVE